Atara Biotherapeutics (ATRA) Enterprise Value (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Enterprise Value of -$8.4 million for Q1 2026, up 1.44% on a QoQ basis from -$8.5 million in Q4 2025, and up 39.6% year-over-year from -$6.0 million in Q1 2025.
Atara Biotherapeutics (ATRA) Enterprise Value (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' Enterprise Value history runs 14 years deep, the most recent figure standing at -$8.4 million for Q1 2026.
- Quarterly Enterprise Value rose 39.6% year-over-year to -$8.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.4 million (up 39.6% YoY) and the FY2025 annual result came in at -$8.5 million, up 66.31% from the prior year.
- Enterprise Value was -$8.4 million for Q1 2026 at Atara Biotherapeutics, up from -$8.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$5.7 million in Q3 2025 and bottomed at -$301.8 million in Q1 2022.
- A 5-year average of -$65.1 million and a median of -$46.2 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 128.48% — and 2025, when it soared 87.68%.
- Atara Biotherapeutics' Enterprise Value stood at -$242.8 million in 2022, then surged by 78.7% to -$51.7 million in 2023, then surged by 51.33% to -$25.2 million in 2024, then jumped by 66.31% to -$8.5 million in 2025, then advanced by 1.44% to -$8.4 million in 2026.
- Business Quant data shows ATRA's Enterprise Value at -$8.4 million in Q1 2026, -$8.5 million in Q4 2025, and -$5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.36 Mn |
| Dec 31, 2025 | -8.48 Mn |
| Sep 30, 2025 | -5.74 Mn |
| Jun 30, 2025 | -22.32 Mn |
| Mar 31, 2025 | -13.84 Mn |
| Dec 31, 2024 | -25.18 Mn |
| Sep 30, 2024 | -46.60 Mn |
| Jun 30, 2024 | -35.29 Mn |
| Mar 31, 2024 | -46.24 Mn |
| Dec 31, 2023 | -51.73 Mn |
| Sep 30, 2023 | -64.94 Mn |
| Jun 30, 2023 | -46.04 Mn |
| Mar 31, 2023 | -48.89 Mn |
| Dec 31, 2022 | -242.82 Mn |
| Sep 30, 2022 | -66.46 Mn |
| Jun 30, 2022 | -72.03 Mn |
| Mar 31, 2022 | -301.81 Mn |
| Dec 31, 2021 | -106.28 Mn |
| Sep 30, 2021 | -357.25 Mn |
| Jun 30, 2021 | -124.05 Mn |